UnknownNot Applicable

STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands

Netherlands10,000 participantsStarted 2019-01-01

Plain-language summary

The aim of this study is to optimize implementation of the opportunistic salpingectomy throughout the Netherlands.

Who can participate

Age range

30 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age from 30 years * Undergoing gynaecological surgery in which currently both ovaries and fallopian tubes would be preserved * Childbearing completed * Able to understand the written or spoken Dutch language * Consent for enrolment in database * Consent for yearly checks of PALGA database and municipal administration Exclusion Criteria: * Age under 30 years * Undergoing surgery without residual ovarian tissue * Child wish * Unable to understand the written or spoken Dutch language * Previous bilateral salpingectomy * Previous bilateral salpingo-oophorectomy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Offered Opportunistic Salpingectomy (OS)

Timeframe: 2019 - 2023

Implementation effect of Opportunistic Salpingectomy (OS)

Timeframe: 2019-2023

Trial details

NCT IDNCT04470921

SponsorRadboud University Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01-01

View on ClinicalTrials.gov More Risk Reduction trials